Risk of Low Blood Sugar (Hypoglycemia): If you are taking GLP-1 medications for type 2 diabetes alongside other blood-sugar-lowering drugs (like insulin or sulfonylureas), drinking alcohol can be risky
The integration of digital technology with diabetes management tools is creating new opportunities for patient engagement and personalized treatment plans
Our findings highlight the therapeutic potential of GLP-1RAs for managing BBS-associated metabolic dysregulation, indicating that further investigation for clinical application is warranted
[1] [7] Other notable effects include injection site reactions beyond pain (erythema, pruritus, induration in 13% of patients), increased heart rate (particularly with liraglutide), gallbladder disease (including gallstones and cholecystitis), and potential dehydration-related acute kidney injury
The platform primarily offers compounded semaglutide (a GLP-1 receptor agonist) and compounded tirzepatide (a dual GIP/GLP-1 agonist) at prices well below brand-name Ozempic, Wegovy, or Mounjaro